InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Moreadith Randall, Chief Scientific Officer. Officer active across 1 companies, notably Serina Therapeutics, Inc.. Aggregated, 26 reports have been published. The latest transaction was disclosed on 2 February 2026 — Levée d'options. Regulator: SEC (Form 4). The full history is openly available.
Declarations26 total
US$3296,500 shares@ US$0.05060.0013% mcap10.2% of flow
Common Stock
SEC:0001301120-26-000012·
€3296,500 shares@ €0.05060.0013% mcap5.1% of flow
Common Stock
SEC:0001301120-26-000012:0·
US$3256,500 shares@ US$0.04990.0013% mcap10.1% of flow
Common Stock
SEC:0001301120-26-000010·
€3256,500 shares@ €0.04990.0013% mcap5.0% of flow
Common Stock
SEC:0001301120-26-000010:0·
US$2795,416 shares@ US$0.05140.0011% mcap8.7% of flow
Common Stock
SEC:0001301120-26-000004·
€2795,416 shares@ €0.05140.0011% mcap4.3% of flow
Common Stock
SEC:0001301120-26-000004:0·
US$66813,000 shares@ US$0.05140.0027% mcap20.8% of flow
Common Stock
SEC:0001301120-26-000002·
€66813,000 shares@ €0.05140.0027% mcap10.4% of flow
Common Stock
SEC:0001301120-26-000002:0·
US$2915,673 shares@ US$0.05120.0012% mcap9.0% of flow
Common Stock
SEC:0001301120-25-000037·
€2915,673 shares@ €0.05120.0012% mcap4.5% of flow
Common Stock
SEC:0001301120-25-000037:0·
US$871,700 shares@ US$0.05110.0004% mcap2.7% of flow
Common Stock
SEC:0001301120-25-000033·
€871,700 shares@ €0.05110.0004% mcap1.3% of flow
Common Stock
SEC:0001301120-25-000033:0·
US$1823,555 shares@ US$0.05130.0007% mcap5.7% of flow
Common Stock
SEC:0001301120-25-000030·
€1823,555 shares@ €0.05130.0007% mcap2.8% of flow
Common Stock
SEC:0001301120-25-000030:0·
US$31600 shares@ US$0.05150.0001% mcap1.0% of flow
Common Stock
SEC:0001301120-25-000027·
€31600 shares@ €0.05150.0001% mcap0.5% of flow
Common Stock
SEC:0001301120-25-000027:0·
US$781,500 shares@ US$0.05170.0003% mcap2.4% of flow
Common Stock
SEC:0001301120-25-000025·
€781,500 shares@ €0.05170.0003% mcap1.2% of flow
Common Stock
SEC:0001301120-25-000025:0·
US$2865,551 shares@ US$0.05150.0012% mcap8.9% of flow
Common Stock
SEC:0001301120-25-000013·
€2865,551 shares@ €0.05150.0012% mcap4.4% of flow
Common Stock
SEC:0001301120-25-000013:0·
US$3356,500 shares@ US$0.05150.0014% mcap10.4% of flow
Common Stock
SEC:0001301120-25-000009·
€3356,500 shares@ €0.05150.0014% mcap5.2% of flow
Common Stock
SEC:0001301120-25-000009:0·
US$2244,326 shares@ US$0.05190.0009% mcap7.0% of flow
Common Stock
SEC:0001301120-25-000007·
€2244,326 shares@ €0.05190.0009% mcap3.5% of flow
Common Stock
SEC:0001301120-25-000007:0·
US$1052,042 shares@ US$0.05160.0004% mcap3.3% of flow
Common Stock
SEC:0001301120-25-000005·
25 of 26 declarations
About Moreadith Randall
Moreadith Randall is the Chief Scientific Officer of Serina Therapeutics, Inc. She oversees the company's research and development initiatives.
